These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
350 related items for PubMed ID: 19909428
1. Tissue Doppler and strain imaging in dogs with myxomatous mitral valve disease in different stages of congestive heart failure. Tidholm A, Ljungvall I, Höglund K, Westling AB, Häggström J. J Vet Intern Med; 2009; 23(6):1197-207. PubMed ID: 19909428 [Abstract] [Full Text] [Related]
2. Usefulness of conventional and tissue Doppler echocardiography to predict congestive heart failure in dogs with myxomatous mitral valve disease. Kim JH, Park HM. J Vet Intern Med; 2015 Jan; 29(1):132-40. PubMed ID: 25270196 [Abstract] [Full Text] [Related]
3. Left atrial deformation and phasic function determined by two-dimensional speckle-tracking echocardiography in dogs with myxomatous mitral valve disease. Caivano D, Rishniw M, Birettoni F, Patata V, Giorgi ME, Porciello F. J Vet Cardiol; 2018 Apr; 20(2):102-114. PubMed ID: 29459124 [Abstract] [Full Text] [Related]
5. Echocardiographic parameters for the assessment of congestive heart failure in dogs with myxomatous mitral valve disease and moderate to severe mitral regurgitation. Morgan KRS, Monteith G, Raheb S, Colpitts M, Fonfara S. Vet J; 2020 Sep; 263():105518. PubMed ID: 32928487 [Abstract] [Full Text] [Related]
6. Radial and longitudinal strain and strain rate assessed by speckle-tracking echocardiography in dogs with myxomatous mitral valve disease. Zois NE, Tidholm A, Nägga KM, Moesgaard SG, Rasmussen CE, Falk T, Häggström J, Pedersen HD, Åblad B, Nilsen HY, Olsen LH. J Vet Intern Med; 2012 Sep; 26(6):1309-19. PubMed ID: 23113772 [Abstract] [Full Text] [Related]
7. Effects of treatment on respiratory rate, serum natriuretic peptide concentration, and Doppler echocardiographic indices of left ventricular filling pressure in dogs with congestive heart failure secondary to degenerative mitral valve disease and dilated cardiomyopathy. Schober KE, Hart TM, Stern JA, Li X, Samii VF, Zekas LJ, Scansen BA, Bonagura JD. J Am Vet Med Assoc; 2011 Aug 15; 239(4):468-79. PubMed ID: 21838584 [Abstract] [Full Text] [Related]
8. Utility of Tissue Doppler Imaging in the Echocardiographic Evaluation of Left and Right Ventricular Function in Dogs with Myxomatous Mitral Valve Disease with or without Pulmonary Hypertension. Baron Toaldo M, Poser H, Menciotti G, Battaia S, Contiero B, Cipone M, Diana A, Mazzotta E, Guglielmini C. J Vet Intern Med; 2016 May 15; 30(3):697-705. PubMed ID: 27177623 [Abstract] [Full Text] [Related]
9. Left ventricular twist and circumferential strain in dogs with myxomatous mitral valve disease. Zois NE, Olsen NT, Moesgaard SG, Rasmussen CE, Falk T, Häggström J, Pedersen HD, Møller JE, Olsen LH. J Vet Intern Med; 2013 May 15; 27(4):875-83. PubMed ID: 23731222 [Abstract] [Full Text] [Related]
10. Selected echocardiographic variables change more rapidly in dogs that die from myxomatous mitral valve disease. Hezzell MJ, Boswood A, Moonarmart W, Elliott J. J Vet Cardiol; 2012 Mar 15; 14(1):269-79. PubMed ID: 22366569 [Abstract] [Full Text] [Related]
11. Effect of pimobendan or benazepril hydrochloride on survival times in dogs with congestive heart failure caused by naturally occurring myxomatous mitral valve disease: the QUEST study. Häggström J, Boswood A, O'Grady M, Jöns O, Smith S, Swift S, Borgarelli M, Gavaghan B, Kresken JG, Patteson M, Ablad B, Bussadori CM, Glaus T, Kovacević A, Rapp M, Santilli RA, Tidholm A, Eriksson A, Belanger MC, Deinert M, Little CJ, Kvart C, French A, Rønn-Landbo M, Wess G, Eggertsdottir AV, O'Sullivan ML, Schneider M, Lombard CW, Dukes-McEwan J, Willis R, Louvet A, DiFruscia R. J Vet Intern Med; 2008 Mar 15; 22(5):1124-35. PubMed ID: 18638016 [Abstract] [Full Text] [Related]
12. Tissue Doppler imaging in patients with advanced heart failure: relation to functional class and prognosis. Hamdan A, Shapira Y, Bengal T, Mansur M, Vaturi M, Sulkes J, Battler A, Sagie A. J Heart Lung Transplant; 2006 Feb 15; 25(2):214-8. PubMed ID: 16446223 [Abstract] [Full Text] [Related]
13. Left atrial ejection fraction assessed by real-time 3-dimensional echocardiography in normal dogs and dogs with myxomatous mitral valve disease. Tidholm A, Höglund K, Häggström J, Bodegård-Westling A, Ljungvall I. J Vet Intern Med; 2013 Feb 15; 27(4):884-9. PubMed ID: 23731204 [Abstract] [Full Text] [Related]
14. Longitudinal analysis of quality of life, clinical, radiographic, echocardiographic, and laboratory variables in dogs with myxomatous mitral valve disease receiving pimobendan or benazepril: the QUEST study. Häggström J, Boswood A, O'Grady M, Jöns O, Smith S, Swift S, Borgarelli M, Gavaghan B, Kresken JG, Patteson M, Åblad B, Bussadori CM, Glaus T, Kovačević A, Rapp M, Santilli RA, Tidholm A, Eriksson A, Belanger MC, Deinert M, Little CJ, Kvart C, French A, Rønn-Landbo M, Wess G, Eggertsdottir A, Lynne O'Sullivan M, Schneider M, Lombard CW, Dukes-McEwan J, Willis R, Louvet A, DiFruscia R. J Vet Intern Med; 2013 Feb 15; 27(6):1441-51. PubMed ID: 24010489 [Abstract] [Full Text] [Related]
15. Temporal changes in clinical and radiographic variables in dogs with preclinical myxomatous mitral valve disease: The EPIC study. Boswood A, Gordon SG, Häggström J, Vanselow M, Wess G, Stepien RL, Oyama MA, Keene BW, Bonagura J, MacDonald KA, Patteson M, Smith S, Fox PR, Sanderson K, Woolley R, Szatmári V, Menaut P, Church WM, O'Sullivan ML, Jaudon JP, Kresken JG, Rush J, Barrett KA, Rosenthal SL, Saunders AB, Ljungvall I, Deinert M, Bomassi E, Estrada AH, Fernandez Del Palacio MJ, Moise NS, Abbott JA, Fujii Y, Spier A, Luethy MW, Santilli RA, Uechi M, Tidholm A, Schummer C, Watson P. J Vet Intern Med; 2020 May 15; 34(3):1108-1118. PubMed ID: 32200574 [Abstract] [Full Text] [Related]
16. Heart rate, heart rate variability, and arrhythmias in dogs with myxomatous mitral valve disease. Rasmussen CE, Falk T, Zois NE, Moesgaard SG, Häggström J, Pedersen HD, Ablad B, Nilsen HY, Olsen LH. J Vet Intern Med; 2012 May 15; 26(1):76-84. PubMed ID: 22151356 [Abstract] [Full Text] [Related]
17. Assessment of left ventricular function using mitral annular velocities in patients with congestive heart failure with or without the presence of significant mitral regurgitation. Alam M, Wardell J, Andersson E, Nordlander R, Samad B. J Am Soc Echocardiogr; 2003 Mar 15; 16(3):240-5. PubMed ID: 12618732 [Abstract] [Full Text] [Related]
18. Short-term hemodynamic and neuroendocrine effects of pimobendan and benazapril in dogs with myxomatous mitral valve disease and congestive heart failure. Häggström J, Lord PF, Höglund K, Ljungvall I, Jöns O, Kvart C, Hansson K. J Vet Intern Med; 2013 Mar 15; 27(6):1452-62. PubMed ID: 24128373 [Abstract] [Full Text] [Related]
19. Assessment of global and regional left ventricular volume and shape by real-time 3-dimensional echocardiography in dogs with myxomatous mitral valve disease. Ljungvall I, Höglund K, Carnabuci C, Tidholm A, Häggström J. J Vet Intern Med; 2011 Mar 15; 25(5):1036-43. PubMed ID: 21848946 [Abstract] [Full Text] [Related]
20. Partial external mitral annuloplasty in dogs with myxomatous mitral valve degeneration and congestive heart failure: outcome in 9 cases. de Andrade JN, Christopher Orton E, Boon J, Nishimori CT, Olivaes C, Camacho AA. J Vet Cardiol; 2011 Sep 15; 13(3):197-201. PubMed ID: 21824833 [Abstract] [Full Text] [Related] Page: [Next] [New Search]